Search results for "Drug Industry"

showing 3 items of 23 documents

Palladium coupling catalysts for pharmaceutical applications

2007

International audience; This review discusses recent advances made in the area of palladium-catalyzed coupling reactions and describes a selection of the catalytic systems that are useful in the preparation of valuable compounds for the pharmaceutical industry. Most of these types of syntheses have used either simple palladium salts or palladium precursors associated with electron-rich mono- or bidentate phosphine ligands as catalysts. For some reactions, ligands such as triphenyl phosphine, 1,1'-bis(diphenylphosphino)ferrocene, a carbene or a bipyridine have also been employed. Several new procedures for the Suzuki cross-coupling reaction, the activation of aryl chlorides, the functionaliz…

[ CHIM.CATA ] Chemical Sciences/CatalysisDrug IndustryMolecular StructurePharmaceutical PreparationsDrug Design[CHIM.CATA] Chemical Sciences/Catalysis[CHIM.CATA]Chemical Sciences/CatalysisCatalysisPalladiumComputingMilieux_MISCELLANEOUS
researchProduct

Exploring why global health needs are unmet by research efforts: the potential influences of geography, industry and publication incentives

2020

[Background]: It has been well established that research is not addressing health needs in a balanced way — much more research is conducted on diseases with more burden in high-income countries than on those with more burden in lower-income countries. In this study, we explore whether these imbalances persist and inquire about the possible influence of three factors, namely geography, industry and publication incentives.

medicine.medical_specialtyBiomedical ResearchDrug IndustryInternational Cooperationburden of diseaseGlobal Health050905 science studiesunmet health needspharmaceutical industryHealth administrationresearch evaluation03 medical and health sciences0302 clinical medicineCost of IllnessDevelopment economicsGlobal healthmedicineHumansAttention030212 general & internal medicinepublication incentivesDeveloping CountriesHealth policyDisease burdenPublishingHealth Services Needs and DemandMotivationPublic SectorGeographyHealth Prioritiesbusiness.industryDeveloped CountriesResearchHealth PolicyPublic healthlcsh:Public aspects of medicine05 social sciencesPublic sectorHealth services researchlcsh:RA1-1270ClassificationResearch PersonnelIncentiveresearch prioritiesBibliometricsJournal Impact Factor0509 other social sciencesbusiness
researchProduct

The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.

2021

medicine.medical_specialtyDrug Industrybusiness.industryGeneral NeuroscienceMEDLINEGeneral MedicineDiseaseAntibodies Monoclonal HumanizedRaising (linguistics)United StatesPsychiatry and Mental healthClinical PsychologyAlzheimer DiseaseMedicineHumansAducanumabGeriatrics and GerontologybusinessIntensive care medicineDrug ApprovalJournal of Alzheimer's disease : JAD
researchProduct